Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |